About demyelinating properties of humoral antibodies in experimental allergic encephalomyelitis. In vivo and in vitro studies
- PMID: 65100
- DOI: 10.1007/BF00699636
About demyelinating properties of humoral antibodies in experimental allergic encephalomyelitis. In vivo and in vitro studies
Abstract
In order to elucidate the role of humoral antibodies in the pathogenesis of myelin lesions in experimental allergic encephalomyelitis (EAE) a combined in vivo and in vitro study was done using rabbits immunized with the purified A1 basic protein. Rabbits injected with whole white matter were used for comparison. Demyelinating activity appeared in the rabbit sera 5 days after injection, as tested in myelinated organotypic tissue cultures. In spite of this no lesions of the myelin preceded the appearance of inflammatory cells in the living animals. In the spinal cord changes in vascular permeability, as revealed by leakage of Evans blue-albumin complex, appeared at the same time as the cells. In contrast to in vitro, the mere presence of circulating antibodies in vivo does not appear to be enough to cause structural changes of the myelin. Possible reasons for this discrepancy are discussed; it is emphasized that the inflammatory changes develope first in areas where the so-called blood-brain barrier to diffusion of proteins is lacking.
Similar articles
-
Myelin-binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis, anti-galactocerebroside and multiple sclerosis sera.Brain Res. 1978 Dec 22;159(1):173-82. doi: 10.1016/0006-8993(78)90118-x. Brain Res. 1978. PMID: 83176 No abstract available.
-
Myelination inhibition factor: dissociation from induction of experimental allergic encephalomyelitis.Science. 1973 Feb 16;179(4074):689-90. doi: 10.1126/science.179.4074.689. Science. 1973. PMID: 4119452
-
Magnetic resonance imaging of antibody-mediated demyelinating experimental allergic encephalomyelitis.J Neuroimmunol. 1994 Oct;54(1-2):41-50. doi: 10.1016/0165-5728(94)90229-1. J Neuroimmunol. 1994. PMID: 7929802
-
Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis.Biomedicine. 1975 Mar;22(2):81-7. Biomedicine. 1975. PMID: 55276 Review.
-
[Demyelination and autoimmunity].Pathol Biol (Paris). 1987 Mar;35(3):275-83. Pathol Biol (Paris). 1987. PMID: 3295694 Review. French.
Cited by
-
Chronic relapsing experimental allergic encephalomyelitis. Studies in vascular permeability changes.Acta Neuropathol. 1977 Aug 31;39(3):189-94. doi: 10.1007/BF00691696. Acta Neuropathol. 1977. PMID: 906801
-
Multiple sclerosis: demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological diseases.J Neurol. 1978 Apr 14;218(1):7-16. doi: 10.1007/BF00314713. J Neurol. 1978. PMID: 77321
-
Localization of toxic encephalopathies near lesions of experimental allergic encephalomyelitis.Am J Pathol. 1982 May;107(2):135-41. Am J Pathol. 1982. PMID: 6979257 Free PMC article.
-
Autoimmune encephalomyelitis in rhesus monkeys induced by immunization with cerebral endothelial cell membrane.Acta Neuropathol. 1988;77(1):39-46. doi: 10.1007/BF00688241. Acta Neuropathol. 1988. PMID: 3239374
-
In vivo demyelination by antimyelin antibodies.Acta Neuropathol. 1980;50(1):1-8. doi: 10.1007/BF00688528. Acta Neuropathol. 1980. PMID: 7376824